|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：N391700 |
| 產(chǎn)品名稱：NF449 |
| 產(chǎn)品CAS：627034-85-9 |
| 規(guī)格含量：25mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
N391700 |
| 名稱: |
NF449 |
| 別名: |
4,4',4'',4'''-[Carbonylbis[imino-5,1,3-benzenetriylbis(carbonylimino)]]tetrakis-1,3-Benzenedisulfonic Acid Sodium Salt (1:8); 4,4',4'',4'''-[Carbonylbis[imino-5,1,3-benzenetriylbis(carbonylimino)]]tetrakis-1,3-benzenedisulfonic Acid Octasodium Salt; |
| CAS號(hào): |
627034-85-9 |
| 分子式: |
C??H??N?Na?O??S? |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
>300°C |
| 分子量: |
1505.09 |
| 儲(chǔ)存: |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
| 溶解度: |
Aqueous Acid (Slightly), Water (Slightly) |
| 穩(wěn)定性: |
Hygroscopic |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
NF449 is a known P2X1 receptor antagonist used to regulate the intravascular platelet aggregation commonly seen in systematic thromboembolism. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
